Boothe Investment Group, Inc. Lexicon Pharmaceuticals, Inc. Transaction History

Boothe Investment Group, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 06, 2021	SELL	$3.38 - $5.35 $1.58 Million - $2.5 Million	-467,919 Closed	0 $0
Q2 2021 Jul 28, 2021	BUY	$4.12 - $5.87 $131,757 - $187,722	31,980 Added 7.34%	467,919 $2.04 Million
Q1 2021 Apr 06, 2021	BUY	$3.45 - $9.09 $1.5 Million - $3.96 Million	435,939 New	435,939 $2.56 Million

141

238M

459K

133K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $145M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of Boothe Investment Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Boothe Investment Group, Inc. with notifications on news.